|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 3 of 3
Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | article | Ken, Ito; Satoshi, Yuki; Hiroshi, Nakatsumi; Kawamoto, Yasuyuki; Harada, Kazuaki; Nakano, Shintaro; Saito, Rika; Ando, Takayuki; Sawada, Kentaro; Yagisawa, Masataka; Ishiguro, Atsushi; Dazai, Masayoshi; Iwanaga, Ichiro; Hatanaka, Kazuteru; Sato, Atsushi; Matsumoto, Ryusuke; Shindo, Yoshiaki; Tateyama, Miki; Muranaka, Tetsuhito; Katagiri, Masaki; Yokota, Isao; Sakata, Yuh; Sakamoto, Naoya; Komatsu, Yoshito | Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer | - | Supportive Care in Cancer | - | 1-Jun-2022 |
article | Nakatsumi, Hiroshi; Komatsu, Yoshito; Muranaka, Tetsuhito; Yuki, Satoshi; Kawamoto, Yasuyuki; Harada, Kazuaki; Dazai, Masayoshi; Tateyama, Miki; Sasaki, Yusuke; Miyagishima, Takuto; Tsuji, Yasushi; Katagiri, Masaki; Nakamura, Michio; Sogabe, Susumu; Hatanaka, Kazuteru; Meguro, Takashi; Kobayashi, Tomoe; Ishiguro, Atsushi; Muto, Osamu; Shindo, Yoshiaki; Kotaka, Masahito; Ando, Takayuki; Takagi, Ryo; Sakamoto, Naoya; Sakata, Yu | Study protocol for HGCSG1801 : A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies | - | Frontiers in oncology | - | 9-Nov-2022 |
article | Nakano, Shintaro; Kawamoto, Yasuyuki; Yuki, Satoshi; Harada, Kazuaki; Miyagishima, Takuto; Sogabe, Susumu; Dazai, Masayoshi; Sato, Atsushi; Ishiguro, Atsushi; Nakamura, Michio; Kajiura, Shinya; Takahashi, Yasuo; Tateyama, Miki; Hatanaka, Kazuteru; Tsuji, Yasushi; Sasaki, Takahide; Shindo, Yoshiaki; Kobayashi, Tomoe; Yokota, Isao; Sakamoto, Naoya; Sakata, Yuh; Komatsu, Yoshito | Study protocol of the HGCSG1803 : a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer | - | BMJ Open | - | May-2022 |
Showing results 1 to 3 of 3
|